Azari-Dolatabad Nima, Raes Annelies, Pavani Krishna Chaitanya, Asaadi Anise, Angel-Velez Daniel, Van Damme Petra, Leroy Jo L M R, Van Soom Ann, Pascottini Osvaldo Bogado
Department of Reproduction, Obstetrics and Herd Health, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Department of Reproduction, Obstetrics and Herd Health, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Theriogenology. 2021 May;166:38-45. doi: 10.1016/j.theriogenology.2021.02.016. Epub 2021 Feb 25.
We evaluated the effect of supplementation of different concentrations of bovine follicular fluid (FF) during in vitro maturation (IVM) on oocyte development and blastocyst quality in group and individual culture conditions. To do so, in vitro maturation medium (TCM-199 with 20 ng/mL epidermal growth factor and 50 μg/mL gentamycin) was supplemented with 0 (control), 1, 5, or 10% of FF. Follicular fluid was collected from slaughterhouse-derived ovaries, selecting follicles between 12 and 20 mm in diameter. Oocytes were either produced in groups or individually matured, fertilized, and cultured to the blastocyst stage, allowing for separate follow-up of each oocyte. Development (cleavage and blastocyst rates) among experimental groups were fitted in mixed-effects models, and blastocyst quality parameters (assessed via differential apoptotic staining) were evaluated in mixed linear regression models. We also assessed the cumulus expansion (prior and after maturation) for individual culture conditions, and their difference was fitted in mixed linear regression models. The FF was collected from two batches, with an estradiol/progesterone ratio higher than 1. The FF batch did not affect the development or blastocyst quality in group or individual culture conditions (P > 0.05). In group culture, development was similar among experimental groups (P > 0.05). Five or 10% of FF supplementation improved (P ˂ 0.05) aspects of blastocyst quality such as total cell numbers (TCN), trophectoderm (TE), inner cell mass (ICM), and ICM/TCN and apoptotic cells/TCN ratio in comparison to control. In the individual culture system, 5% FF supplementation increased (P ˂ 0.05) day 8 blastocyst rate (33 ± 3.4% (LSM ± SE)) in comparison to control (20 ± 2.7%) and 1% FF supplementation (19 ± 2.6%) but it was not different (P > 0.05) from 10% FF supplementation (28 ± 3.4%). Five percent of FF supplementation resulted in greater TCN, ICM, and ICM/TCN than control (P ˂ 0.05). It also resulted in a greater expansion of cumulus cell investment than the other groups (P ˂ 0.05), with a 3-fold increase compared to control. In conclusion, 5% of FF supplementation during IVM improved the cumulus expansion and the blastocyst development and quality in an individual culture system. However, FF supplementation during maturation in a group culture system did not increase development, but it modestly improved some embryo quality aspects when 5 or 10% of FF was added.
我们评估了在体外成熟(IVM)过程中添加不同浓度的牛卵泡液(FF)对群体培养和个体培养条件下卵母细胞发育及囊胚质量的影响。为此,在体外成熟培养基(添加20 ng/mL表皮生长因子和50 μg/mL庆大霉素的TCM - 199)中分别添加0(对照)、1%、5%或10%的FF。卵泡液从屠宰场获取的卵巢中收集,选取直径在12至20 mm之间的卵泡。卵母细胞分别在群体培养或个体培养条件下进行成熟、受精并培养至囊胚阶段,以便对每个卵母细胞进行单独跟踪。实验分组间的发育情况(卵裂率和囊胚率)采用混合效应模型进行拟合,囊胚质量参数(通过差异凋亡染色评估)采用混合线性回归模型进行评估。我们还评估了个体培养条件下卵丘扩展情况(成熟前后),并采用混合线性回归模型对其差异进行拟合。FF收集自两批,雌二醇/孕酮比值高于1。FF批次在群体培养或个体培养条件下均不影响发育或囊胚质量(P > 0.05)。在群体培养中,各实验组发育情况相似(P > 0.05)。与对照组相比,添加5%或10%的FF可改善囊胚质量的多个方面,如总细胞数(TCN)、滋养外胚层(TE)、内细胞团(ICM)、ICM/TCN以及凋亡细胞/TCN比值(P < 0.05)。在个体培养系统中,与对照组(20 ± 2.7%)和添加1% FF组(19 ± 2.6%)相比,添加5% FF可提高第8天的囊胚率(33 ± 3.4%(最小二乘均值 ± 标准误)),但与添加10% FF组(28 ± 3.4%)相比无差异(P > 0.05)。添加5% FF导致TCN、ICM和ICM/TCN均高于对照组(P < 0.05)。与其他组相比,其还导致卵丘细胞扩展程度更大(P < 0.05),与对照组相比增加了3倍。总之,IVM期间添加5%的FF可改善个体培养系统中的卵丘扩展、囊胚发育及质量。然而,在群体培养系统中成熟过程中添加FF并未增加发育率,但添加5%或10%的FF时可适度改善某些胚胎质量方面。